Evidence map›Paper›PMID 38899036›Full record

ReviewRSC advances2024

Recent advances on anticancer and antimicrobial activities of directly-fluorinated five-membered heterocycles and their benzo-fused systems.

Ashraf A Abbas, Thoraya A Farghaly, Kamal M Dawood

Abstract readReview
In one paragraph

Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. 4-methylbenzyl 5-arylthiophene-2-carboxylates as Multitarget Directed Ligands Scaffolds (MTDLs): Synthesis, in-silico docking studies, and evaluation of dual selective enzymatic inhibition (AChE & MAO-B).Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Recent Advances: Heterocycles in Drugs and Drug Discovery.International journal of molecular sciences · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ashraf A AbbasDepartment of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +202 35727556.ORCID https://orcid.org/0000-0001-7061-9907
Thoraya A FarghalyDepartment of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +202 35727556.ORCID https://orcid.org/0000-0002-9620-8548
Kamal M DawoodDepartment of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +202 35727556.ORCID https://orcid.org/0000-0002-1351-9886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the importance of the fluorinated heterocycles as main components of marketed drugs where 20% of the anticancer and antibiotic drugs contain fluorine atoms, this review describes the reported five-membered heterocycles and their benzo-fused systems having directly connected fluorine atom(s). The

Identifiers

PMID38899036
PMCPMC11185950

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.